![Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme | European Respiratory Society Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme | European Respiratory Society](https://erj.ersjournals.com/content/erj/55/4/1901872/F5.large.jpg)
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme | European Respiratory Society
![Table 1 from Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. | Semantic Scholar Table 1 from Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c6b8d0ee7b688da71e94900d540176f65e3c1d22/54-Table1-1.png)
Table 1 from Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. | Semantic Scholar
![Preventer inhaler use overall and by short-acting beta agonist (SABA)... | Download Scientific Diagram Preventer inhaler use overall and by short-acting beta agonist (SABA)... | Download Scientific Diagram](https://www.researchgate.net/publication/335188173/figure/tbl2/AS:792155920560129@1565876097478/Preventer-inhaler-use-overall-and-by-short-acting-beta-agonist-SABA-overuse-versus.png)
Preventer inhaler use overall and by short-acting beta agonist (SABA)... | Download Scientific Diagram
![The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura, The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura,](https://journals.sagepub.com/cms/10.1177/14799731231166008/asset/images/large/10.1177_14799731231166008-fig2.jpeg)
The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura,
![Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany | Respiratory Research | Full Text Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-021-01701-3/MediaObjects/12931_2021_1701_Fig2_HTML.png)
Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany | Respiratory Research | Full Text
![PDF] Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. | Semantic Scholar PDF] Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d73463e4ea09f709b9cda0d08c40cc8c4fba91ee/93-Table1-1.png)
PDF] Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. | Semantic Scholar
![Expert Consensus on SABA Use for Asthma Clinical Decision-Making: A Delphi Approach | Current Allergy and Asthma Reports Expert Consensus on SABA Use for Asthma Clinical Decision-Making: A Delphi Approach | Current Allergy and Asthma Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11882-023-01111-z/MediaObjects/11882_2023_1111_Fig1_HTML.png)
Expert Consensus on SABA Use for Asthma Clinical Decision-Making: A Delphi Approach | Current Allergy and Asthma Reports
![Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America - ScienceDirect Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213219822002859-gr3.jpg)
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America - ScienceDirect
![Beta-2 agonists mnemonic ... #Salmeterol #Formoterol | Pharmacology nursing, Pharmacology, Education help Beta-2 agonists mnemonic ... #Salmeterol #Formoterol | Pharmacology nursing, Pharmacology, Education help](https://i.pinimg.com/originals/ff/40/91/ff409160a6bcf547dac5505fcd3e5373.jpg)
Beta-2 agonists mnemonic ... #Salmeterol #Formoterol | Pharmacology nursing, Pharmacology, Education help
![Respiratory - Beta2-agonists: salbutamol, salmeterol, formoterol, terbutaline Flashcards by matthew ally | Brainscape Respiratory - Beta2-agonists: salbutamol, salmeterol, formoterol, terbutaline Flashcards by matthew ally | Brainscape](https://s3.amazonaws.com/brainscape-prod/system/cm/243/476/816/q_image_ios.jpg?1524741679)
Respiratory - Beta2-agonists: salbutamol, salmeterol, formoterol, terbutaline Flashcards by matthew ally | Brainscape
![Fixed-dose combination of inhaled corticosteroid and long-acting beta 2... | Download Scientific Diagram Fixed-dose combination of inhaled corticosteroid and long-acting beta 2... | Download Scientific Diagram](https://www.researchgate.net/profile/Kiat-Ruxrungtham/publication/291517568/figure/tbl1/AS:787744762642436@1564824395441/Fixed-dose-combination-of-inhaled-corticosteroid-and-long-acting-beta-2-agonist-in-the.png)